Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors
Clinical trial NCT06947291 · RECRUITING
Trial details
- NCT number
- NCT06947291
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-04
- Primary completion
- 2027-04-30
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.